PODD 株価分析 — Insulet Corporation (Healthcare >> Medical Devices)
PODD に関するよくある質問
PODDのPER(株価収益率)は?
Insulet Corporation(PODD)は現在PER 30.79倍で取引されています。
PODDのROE(自己資本利益率)は?
Insulet CorporationのROEは26.39%です。
PODDの配当利回りは?
Insulet Corporationの配当利回りは0.00%です。
PODDの品質スコア(Quality Score)は?
当社のAIはPODDの総合財務品質を100点中77点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
PODDは今が買い時ですか?
当社AIのタイミングスコアは100点中26点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
PODDはどのセクターに属しますか?
Insulet CorporationはHealthcare >> Medical Devicesセクターに分類されます(NASDAQ市場)
PODD AI Analysis Summary
Our AI summary for PODD: Insulet Corporation (NASDAQ), Healthcare >> Medical Devices sector. The stock currently trades at a P/E of 30.79, ROE of 26.39%, a dividend yield of 0.00%. Its financial Quality Score stands at 77/100 — mid-range fundamentals relative to the market. The AI Timing Score is 26/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 133.26
Price
-33.56
(-20.12%)
Day Change
|
|
|---|
PODD, ファンダメンタルスコアはgood ( ファンダメンタル = 77) but テクニカルスコアは ...(Sign In to See)...
- Signal
- OUTPERFORM
- Signal Description
- Company financial health is Good
- Reason
-
昨年度のROEが一昨年比で低い
ROAがROEに比べて低い
Last-year ROA is lower than last-2-years ROA.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not quite good , financial health is not good , and ability to make profit is ok , ...
| Deepscope 分析 |
|
54% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 85 |
| Magic Formula Rank by ROA |
1518
|
| Magic Formula Rank by ROE |
1518
|
| Magic Formula Rank by ROIC |
1190
|
| Price | 133.26 |
| PBV / Sector |
8.12 / 4.62
|
| Earning Per Share | 4.33 |
| PE / Sector |
30.79 / 32.46
|
| PEG or PE/Growth / Sector |
N/A / 0.50
|
| Average 1M Daily Value |
251.99 M
GREAT
|
| Average 1W Daily Value |
376.90 M
GREAT
|
| Timing Factors |
|
28% |
| Financial Health |
|
47% |
| ポイントになる統計 |
|
66% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-08-06 08:00:31 |
| Symbol | PODD |
| Name | INSULET CORPORATION |
| Sector | Healthcare >> Medical Devices |
| Market | NASDAQ |
| Listed Shares | 69.26 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 11,554.73 / 20,302.66 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 100 Nagog Park, Acton, MA, United States, 01720
Phone: 978 600 7000
Website: https://www.insulet.com
Employees: 5,400
Sector: Healthcare >> Medical Devices
Description: Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Medical Devices
Click a bubble to view stock details · Bubble size represents market capitalization share
Google